TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 55 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $35,051,000 | -18.4% | 244,686 | -12.0% | 6.05% | -18.8% |
| Q4 2015 | $42,955,000 | +8.2% | 277,936 | 0.0% | 7.45% | +14.4% |
| Q3 2015 | $39,714,000 | -0.6% | 277,936 | 0.0% | 6.51% | +7.9% |
| Q2 2015 | $39,937,000 | +1.9% | 277,936 | 0.0% | 6.03% | -42.7% |
| Q1 2015 | $39,197,000 | -4.8% | 277,936 | 0.0% | 10.53% | +44.3% |
| Q4 2014 | $41,187,000 | -3.7% | 277,936 | 0.0% | 7.30% | +53.3% |
| Q3 2014 | $42,763,000 | +9.7% | 277,936 | 0.0% | 4.76% | -17.5% |
| Q2 2014 | $38,978,000 | +24.7% | 277,936 | -1.3% | 5.77% | -8.3% |
| Q1 2014 | $31,267,000 | -33.0% | 281,687 | -40.3% | 6.29% | -38.2% |
| Q4 2013 | $46,694,000 | +30.1% | 472,135 | 0.0% | 10.17% | -28.7% |
| Q3 2013 | $35,882,000 | +36.5% | 472,135 | +0.4% | 14.26% | +36.5% |
| Q2 2013 | $26,292,000 | – | 470,344 | – | 10.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |